{
    "2019-08-14": [
        [
            {
                "time": "2019-08-13",
                "original_text": "After Hours Most Active for Aug 13, 2019: QQQ, PFE, INTC, AKRX, CLVS, AMD, CMCSA, DOW, KMI, KDP, HPQ, SQ",
                "features": {
                    "keywords": [
                        "Most Active",
                        "PFE",
                        "INTC",
                        "AMD"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-13",
                "original_text": "Vaccinex (VCNX) Attains Full Enrollment in Lung Cancer Study",
                "features": {
                    "keywords": [
                        "Vaccinex",
                        "Full Enrollment",
                        "Lung Cancer Study"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-08-13",
                "original_text": "Deciphera's GIST Drug Succeeds in Pivotal Study, Stock Up 80%",
                "features": {
                    "keywords": [
                        "Deciphera",
                        "GIST Drug",
                        "Pivotal Study",
                        "Stock Up"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-13",
                "original_text": "Germany's Stada is &quot;very selective&quot; on acquisitions, CEO says",
                "features": {
                    "keywords": [
                        "Stada",
                        "selective",
                        "acquisitions"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}